AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.10M | -11.41M | -8.08M | -6.35M | -10.90M |
| Total Depreciation and Amortization | 5.50M | 5.30M | 5.59M | 5.75M | 5.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.95M | 7.05M | 3.83M | 3.70M | 5.31M |
| Change in Net Operating Assets | -17.68M | 16.51M | -4.45M | 1.56M | -16.28M |
| Cash from Operations | -15.33M | 17.45M | -3.11M | 4.66M | -15.91M |
| Capital Expenditure | -379.00K | -413.00K | -1.02M | -422.00K | -731.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.77M | -857.00K | -492.00K | -1.20M | -820.00K |
| Cash from Investing | -3.15M | -1.27M | -1.51M | -1.62M | -1.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -99.00K | -97.00K | -95.00K | -92.00K | -91.00K |
| Issuance of Common Stock | -- | -- | 716.00K | 0.00 | 234.00K |
| Repurchase of Common Stock | -1.28M | -11.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.38M | -108.00K | 621.00K | -92.00K | 143.00K |
| Foreign Exchange rate Adjustments | -38.00K | -20.00K | 168.00K | -72.00K | 191.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.89M | 16.05M | -3.83M | 2.88M | -17.13M |